Recent Insider Transactions - Qualigen Therapeutics (NASDAQ: QLGN)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ QLGN Qualigen Therapeutics

Lotz Christopher L. / officer: Vice President of Finance, CFO

07/11/2022

Buy

$0.51

100,000

$51K

100,000

NASDAQ QLGN Qualigen Therapeutics

Ritter Ira E. / director

07/11/2022

Buy

$0.51

40,000

$21K

40,000

NASDAQ QLGN Qualigen Therapeutics

EMERY SIDNEY W JR / director

07/11/2022

Buy

$0.51

40,000

$21K

40,000

NASDAQ QLGN Qualigen Therapeutics

David Richard A. / director

07/11/2022

Buy

$0.51

40,000

$21K

40,000

NASDAQ QLGN Qualigen Therapeutics

Sinha Shishir K. / officer: VP, COO & Secretary

07/11/2022

Buy

$0.51

100,000

$51K

100,000

NASDAQ QLGN Qualigen Therapeutics

BROIDRICK AMY S. / director, officer: President/CSO

07/11/2022

Buy

$0.51

130,000

$67K

130,000

NASDAQ QLGN Qualigen Therapeutics

Poirier Michael S. / officer: Chairman and CEO

06/22/2022

Buy

$0.57

30,000

$17K

199,202

NASDAQ QLGN Qualigen Therapeutics

BROIDRICK AMY S. / officer: President/CSO

06/14/2022

Buy

$0.62

30,000

$19K

34,500